01 7Ocrevus
02 2Ocrevus Royalties
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 3,819
2018 Revenue in Millions : 2,424
Growth (%) : 58
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 845
2019 Revenue in Millions : 688
Growth (%) : 23
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 4,820
2019 Revenue in Millions : 4,131
Growth (%) : 17
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 5,440
2020 Revenue in Millions : 4,586
Growth (%) : 17
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 6,598
2021 Revenue in Millions : 5,440
Growth (%) : 21
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 7,403
2022 Revenue in Millions : 6,598
Growth (%) : 6
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 688
2018 Revenue in Millions : 478
Growth (%) : 44
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 921
2016 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 2,377
2017 Revenue in Millions : 878
Growth (%) : 171%
LOOKING FOR A SUPPLIER?
